News

A labeling mistake has led to a nationwide recall of four different types of Ritz peanut butter cracker sandwich cartons, ...
A Supreme Court jury was shown six “bricks” of a compressed plantlike material during the trial yesterday of a man charged ...
Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...
A journey through the FDA’s newly released complete response letters gave glimpses into the journeys to market for Eli ...
Two Pennsylvania state senators are introducing legislation to legalize adult-use marijuana, aligning with 24 other states.
When the FDA unexpectedly uploaded around 200 drug rejection letters this week, the regulator provided a rare glimpse in | ...
The maker of the Ritz crackers brand has announced a nationwide recall of several sandwich cracker packages and cartons due ...
The Food and Drug Administration (FDA) has updated the labeling for Kisunla ™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer ...
Capricor Therapeutics is expected to release data from the phase 3 HOPE-3 trial in Q3'25, thus presenting a potential path ...
The company said it was optimistic that the issues identified by the Food and Drug Administration could be resolved with new data.
AbbVie, Inc. ABBV and Bristol Myers Squibb BMY are leading drugmakers with broad and diverse portfolios and a global footprint. AbbVie is a global, diversified biopharmaceutical company with a ...
Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapies for disorders of the ...